Status:

UNKNOWN

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Conditions:

Kidney Transplant

Eligibility:

All Genders

19+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the pharmacokinetics and tolerability of Tacrolimus tablet(TacroBell) in kidney transplant recipients.

Detailed Description

This study is a Single center, randomized, open-label, Phase IV study to evaluate the pharmacokinetics and tolerability of Tacrolimus tablet(TacroBell) administration for 24 Weeks in patients after re...

Eligibility Criteria

Inclusion

  • Over 19 years old(male or female)
  • Patients who are planning to receive a kidney from a deceased or a living non-related/related donor
  • Agreement with written informed consent

Exclusion

  • Previously received organs other than kidneys or who are planed to be transplanted simultaneously
  • Diagnosed with cancer in the last five years \[Patients, however, who have recovered from skin cancer (squamous cell/basal cell carcinoma) or thyroid cancer can be enrolled.\]
  • Patients or donors who have positive HIV test result
  • Inadequate for registration under the judgment of the investigator due to severe gastrointestinal disorders
  • Severe systemic infection requiring treatment
  • Prior to the kidney transplantation
  • Treatment with active liver disease or Liver function test(T-bilirubin, Aspartate transaminase(AST), Alanine transaminase(ALT))is over 3 times than upper normal limit
  • White Blood Cell(WBC) \<2.5 x10\^3/μL, or platelet \<75 x10\^3/μL
  • Pregnant women or nursing mothers
  • Fertile women who not practice contraception with appropriate methods
  • Participated in other trial within 4 weeks
  • In investigator's judgment

Key Trial Info

Start Date :

November 30 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 10 2021

Estimated Enrollment :

128 Patients enrolled

Trial Details

Trial ID

NCT04102943

Start Date

November 30 2017

End Date

January 10 2021

Last Update

January 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea